Agreement and Amendment to Merger AgreementAgreement and Amendment to Merger Agreement • April 8th, 2024 • JanOne Inc. • Pharmaceutical preparations
Contract Type FiledApril 8th, 2024 Company IndustryThis Agreement and Amendment to Merger Agreement (“Amendment”) is made as of January [●], 2024 among JanOne Inc., a Nevada corporation (“Acquirer”), Soin Therapeutics, LLC, a Delaware limited liability company (the “Company”), and Amol Soin, M.D. a resident of the State of Ohio (the “Sole Owner ”).
AGREEMENT AND AMENDMENT TO MERGER AGREEMENTAgreement and Amendment to Merger Agreement • November 18th, 2011 • Par Pharmaceutical Companies, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 18th, 2011 Company IndustryThis Agreement and Amendment to the Agreement and Plan of Merger (this “Amendment”) is entered into as of November 17, 2011 by and between Par Pharmaceutical, Inc. (“Parent”) and Admiral Acquisition Corp. (“Merger Sub”), on the one hand, and Anchen Incorporated (the “Company”) and Chih-Ming Chen, Ph.D. (solely with respect to Article XII), on the other hand. Capitalized terms used but not defined herein have the meanings assigned to them in the Merger Agreement (as defined below).